Genomics of disease risk in globally diverse populations
- PMID: 31235872
- DOI: 10.1038/s41576-019-0144-0
Genomics of disease risk in globally diverse populations
Erratum in
-
Author Correction: Genomics of disease risk in globally diverse populations.Nat Rev Genet. 2019 Sep;20(9):562. doi: 10.1038/s41576-019-0153-z. Nat Rev Genet. 2019. PMID: 31270439
Abstract
Risk of disease is multifactorial and can be shaped by socio-economic, demographic, cultural, environmental and genetic factors. Our understanding of the genetic determinants of disease risk has greatly advanced with the advent of genome-wide association studies (GWAS), which detect associations between genetic variants and complex traits or diseases by comparing populations of cases and controls. However, much of this discovery has occurred through GWAS of individuals of European ancestry, with limited representation of other populations, including from Africa, The Americas, Asia and Oceania. Population demography, genetic drift and adaptation to environments over thousands of years have led globally to the diversification of populations. This global genomic diversity can provide new opportunities for discovery and translation into therapies, as well as a better understanding of population disease risk. Large-scale multi-ethnic and representative biobanks and population health resources provide unprecedented opportunities to understand the genetic determinants of disease on a global scale.
Similar articles
-
Genetic analyses of diverse populations improves discovery for complex traits.Nature. 2019 Jun;570(7762):514-518. doi: 10.1038/s41586-019-1310-4. Epub 2019 Jun 19. Nature. 2019. PMID: 31217584 Free PMC article.
-
Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) study.Hum Reprod. 2013 Jun;28(6):1695-706. doi: 10.1093/humrep/det071. Epub 2013 Mar 18. Hum Reprod. 2013. PMID: 23508249 Free PMC article.
-
Assessing the lack of diversity in genetics research across neurodegenerative diseases: a systematic review of the GWAS Catalog and literature.medRxiv [Preprint]. 2024 Jan 9:2024.01.08.24301007. doi: 10.1101/2024.01.08.24301007. medRxiv. 2024. Update in: Alzheimers Dement. 2024 Aug;20(8):5740-5756. doi: 10.1002/alz.13873. PMID: 38260595 Free PMC article. Updated. Preprint.
-
Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Public Health Genomics. 2015;18(1):40-51. doi: 10.1159/000367962. Epub 2014 Nov 26. Public Health Genomics. 2015. PMID: 25427668 Free PMC article. Review.
-
Towards diversity in genomics: The emergence of neurogenomics in Africa?Genomics. 2018 Jan;110(1):1-9. doi: 10.1016/j.ygeno.2017.07.009. Epub 2017 Aug 1. Genomics. 2018. PMID: 28774809 Review.
Cited by
-
Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients.Viruses. 2023 Nov 8;15(11):2227. doi: 10.3390/v15112227. Viruses. 2023. PMID: 38005904 Free PMC article.
-
Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population.Int J Mol Sci. 2022 Oct 4;23(19):11758. doi: 10.3390/ijms231911758. Int J Mol Sci. 2022. PMID: 36233078 Free PMC article.
-
Clinical validation of genomic functional screen data: Analysis of observed BRCA1 variants in an unselected population cohort.HGG Adv. 2022 Jan 8;3(2):100086. doi: 10.1016/j.xhgg.2022.100086. eCollection 2022 Apr 14. HGG Adv. 2022. PMID: 35128484 Free PMC article.
-
Metabolomics and lipidomics strategies in modern drug discovery and development.Drug Discov Today. 2023 Oct;28(10):103751. doi: 10.1016/j.drudis.2023.103751. Epub 2023 Aug 26. Drug Discov Today. 2023. PMID: 37640150 Free PMC article. Review.
-
Harnessing big data to characterize immune-related adverse events.Nat Rev Clin Oncol. 2022 Apr;19(4):269-280. doi: 10.1038/s41571-021-00597-8. Epub 2022 Jan 17. Nat Rev Clin Oncol. 2022. PMID: 35039679 Review.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Medical